Clariant Ag · SIX:CLN
Clariant — Q2 2026 Earnings Presentation
34 slides from Clariant's earnings presentation, Jul 31, 2026
Slide 1: Second Quarter / First Half Year Results 2026
Second Quarter / First Half Year Results 2026 Analyst presentation Investor Relations 31.07.2026
Slide 2: Disclaimer
2 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Disclaimer This presentation contains certain statements that are the Company’s ability to continue to receive adequate neither reported financial results nor other historical products from its vendors on acceptable terms
Slide 3: Group performance
Greater ‘chemistry;
Slide 4: Second Quarter 2026 Key messages
4 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Second Quarter 2026 Key messages Sales of CHF 941.3 m – up 0.6 % in local currency on comparable basis, driven by strong value-based pricing 52 % - 0.3 % across the entire portfolio – marginal LC decline (0.3 %) including
Slide 5: Q2 sales: Care Chemicals and AA with strong pricing and volume growth
5 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Q2 sales:1 CC2 and AA with strong pricing and (underlying) volume growth – CA volumes impacted by Middle East conflict + 0.6 % LC excl. portfolio pruning - 0.3 % LC reported - 2.4 % 967.7 964.4 + 3.0 % - 3.3 % 0.0 % 941.3
Slide 6: Q2 EBITDA b.e.i.: strong performance in Care Chemicals more than offset Middle East impact
6 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Q2 EBITDA b.e.i.:1 strong performance in Care Chemicals more than offset Middle East impact in Catalysts Margin + 80 bps - 70 bps + 170 bps - 10 bps 171.1 - 10 bps 168.5 18.2 % 17.4 % Strong pricing and Middle East confli
Slide 7: Performance improvement programs increased by CHF 20 million to deliver CHF 100 m by 2027
7 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Performance improvement programs (Investor Day 2024) increased by CHF 20 million to deliver CHF 100 m by 2027 Key levers: • SG&A reduction Programs • Footprint optimization Run-rate savings of CHF 100 m • Operational effi
Slide 8: Assessment of Middle East (ME)
8 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Assessment of Middle East (ME) – Operations resumed: All 150 employees are safe, and all Clariant sites (Bahrain, Qatar, UAE, Israel, and Saudi Arabia JV) resumed operations. Globally, feedstock access is secured across t
Slide 9: Q2 2026 Business performance
Q2 2026 Business performance
Slide 10: Second Quarter 2026 Care Chemicals
10 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Second Quarter 2026 Strong underlying growth driven by Care Chemicals consumer facing segments Sales1 (in CHF m) + 4.2 % LC excl. portfolio pruning – Price: Strong increase as value-based pricing offsetting + 1.4 % + 2.5
Slide 11: Second Quarter 2026 Catalysts
11 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Second Quarter 2026 Lower volumes due to ME impact, Catalysts high margin comparable Sales1 (in CHF m) - 13.3 % - 19.1 % – Price: slightly up in all segments 217.9 + 0.9 % - 14.2 % 189.1 0.0 % - 5.8 % 176.2 – Volume: sig
Slide 12: Second Quarter 2026 Adsorbents & Additives
12 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Second Quarter 2026 Strong top-line driven by Additives Adsorbents & Additives (price and volume) Sales (in CHF m) + 5.3 % + 3.4 % – Price: up in all segments to offset inflationary raw 252.9 + 3.3 % + 2.0 % 0.0 % 266.4
Slide 13: First Half Year 2026 Key messages
13 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 First Half Year 2026 Key messages – Sales of CHF 1 859.3 m – Flat in LC excluding portfolio pruning ➔ Middle East volume impact in CA3, offset by underlying 52 % - 1.2 % volume growth in CC and flat AA, Pricing (+ 0.7 %)
Slide 14: Group Outlook
LARIANT Greater chemistry -
Slide 15: Guidance 2026 remains unchanged in challenging and volatile market environment
15 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Guidance 2026 remains unchanged in challenging and volatile market environment impacted by Middle East conflict 2026 guidance (Q1) External factors Internal factors 2026 guidance (Q2) – Middle East (ME) conflict with – P
Slide 16: Appendix
- CLARIANT™ :
Slide 17: Modeling guidance FY 2026 versus FY 2025
17 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Modeling guidance FY 2026 versus FY 2025 • Divestments and closures create a negative top-line impact of 1 % (Group) and Portfolio pruning 2 % (Care Chemicals) to 2026 sales • Growth in Adsorbents & Additives Sales guida
Slide 18: Second Quarter 2026 – Overview
18 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Second Quarter 2026 – Overview Group Care Chemicals in CHF m Q2 2026 Q2 2025 % CHF % LC1 in CHF m Q2 2026 Q2 2025 % CHF % LC1 Sales 941.3 967.7 - 2.7 - 0.3 Sales 503.7 496.9 1.4 2.5 EBITDA 142.4 138.5 2.8 EBITDA 96.7 67.
Slide 19: First Half Year 2026 – Overview
19 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 First Half Year 2026 – Overview Group Care Chemicals in CHF m H1 2026 H1 2025 % CHF % LC1 in CHF m H1 2026 H1 2025 % CHF % LC1 Sales 1 859.3 1 980.7 - 6.1 - 1.2 Sales 1 050.3 1 095.8 - 4.2 0.1 EBITDA 300.2 291.1 3.1 EBIT
Slide 20: First Half Year 2026 – Consolidated Income Statement Highlights
20 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 First Half Year 2026 – Highlights Consolidated Income Statement H1 2026 H1 2025 – Gross margin improved to 31.5 %, strong pricing vs. CHF m % CHF m % Sales 1 859.3 100.0 1 980.7 100.0 higher energy and raw materials Cost
Slide 21: First Half Year 2026 – Cash Flow Statement Highlights
21 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 First Half Year 2026 – Highlights Cash Flow Statement CHF m H1 2026 H1 2025 Net income 85.0 44.2 Adjustment for: Depreciation and amortization 117.1 122.8 – Net cash generated from operating activities increased by Impai
Slide 22: First Half Year 2026 – Balance Sheet
22 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 First Half Year 2026 – Balance Sheet 30.06.2026 31.12.2025 30.06.2026 31.12.2025 ASSETS CHF m % CHF m % EQUITY AND LIABILITIES CHF m % CHF m % Non-current assets Equity Property, plant, and equipment 1 337.7 1 357.2 Shar
Slide 23: Geographic split
23 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Geographic split Q2 sales CHF 941.3 m H1 sales CHF 1 859.3 m in CHF m, % in local currency1 in CHF m, % in local currency1 Asia-Pacific Asia-Pacific 276.5 / + 7.8 % 536.4 / + 9.2 % China 99.3 / - 8.3 % China 194.0 / + 0.
Slide 24: EBITDA / EBIT Bridge First Half Year 2026
24 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 EBITDA / EBIT Bridge First Half Year 2026 Group (CHF m) Care Chemicals (CHF m) EBITDA Exceptional Exceptional EBITDA Exceptional Exceptional bei items EBITDA D&I1 EBITA Amortization EBIT items EBIT bei bei items EBITDA D
Slide 25: ROIC vs. cost of capital Future improvement drivers
25 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 ROIC vs. cost of capital Future improvement drivers Cost of ROIC1 capital: in % 3 ~ 8.0 % − Organic growth 10.6 % 9.9 % 9.5 %4 9.2 % 7.7 % 2 − Increasing operating margin 7.4 % 8.0 % 6.9 % − Reducing nonoperating cost −
Slide 26: Cost dynamics – year on year and sequentially mixed
26 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Cost dynamics – year on year and Pricing and volumes stable sequentially mixed around the flat line − Raw materials in Q2 up 7.4 % YoY (sequential up 11.4 %) − Low-growth economic environment with inflationary raw materi
Slide 27: Exposure to attractive consumer markets of close to 50 %
27 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Exposure to attractive consumer markets of close to 50 %... …with accelerating demand for sustainable products Sales by End Market 2021 (Total Group) Sales by End Market Q2 LTM 20261 Chemical Chemical Process Process Con
Slide 28: ESG – Clariant's sustainability transformation commitment
28 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 ESG – Clariant’s sustainability transformation commitment Sustainability priorities Investment in operations and portfolio Fighting climate change Increasing circularity Sustainable operations Reducing our own carbon Pro
Slide 29: Clariant's leading sustainability ratings and rankings
29 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Clariant’s leading sustainability ratings and rankings Status as of March 2026 Index / Ranking / Clariant Score / Percentile First Year of Status / Comments Rating Rank or Range Inclusion 19% 20% 27% 19% AA to A with 202
Slide 30: Significant improvement of non-financial KPIs – on track for 2030 GHG targets
30 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Significant improvement of non-financial KPIs – fully on track to deliver updated 2030 greenhouse gas (GHG) targets Reducing corporate GHG emissions New operating model driving customer satisfaction and 46.9 % reduction
Slide 31: Calendar of upcoming corporate events
31 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 Calendar of upcoming corporate events 3 November 2026 7 April 2027 Third Quarter / AGM 2027 Nine Month 2026 Reporting 31 July 2026 23 February 2027 Second Quarter / Fourth Quarter / Half Year 2026 Full Year 2026 Reportin
Slide 32: The Executive Leadership Team
32 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 The Executive Leadership Team Conrad Keijzer Chief Executive Officer Executive Leadership Team Executive Steering Committee Marcelo Lu Jens Cuntze Angela Cackovich Oliver Rittgen Priya Thaman Judith Bischof Richard Haldi
Slide 33: IR contacts
33 Second Quarter / First Half Year Results 2026 Investor Relations, 31.07.2026 IR contacts ANDREAS SCHWARZWÄLDER Head of Investor Relations Phone: +41 61 469 63 73 Email: investor-relations@clariant.com THIJS BOUWENS Investor Relations Officer Phone: +41 61 469 63 73 Email: investor-relations@clari
Slide 34: Thank you
Thank you We place great value on understanding the current views of our investment community. Therefore, we would greatly appreciate your input and feedback via www.clariant.com/Investors/Feedback. Your information will be collected via the secure platform of QuantiFire, who manages this process on